Abstract
A serious flaw of many chemotherapeutics employed now for the (post-surgery) treatment of malignant tumors is their high cytotoxicity against vital organs. In addition, tumor cells that survive chemotherapy often show pronounced drug resistance against a wide range of therapeutics. Recently, glycyrrhetinic acid derivatives derived from a cheap and easy-to-obtain natural product have attracted pharmacological interest. Many derivatives of glycyrrhetinic acid showed good to excellent cytotoxicity and inhibited the proliferation of a wide range of human tumor cells. They act predominantly by apoptosis, thus making them an interesting and even fascinating starting point for the development of selective, effective and safe antitumor active drugs.
Keywords: Antitumor activity, apoptosis, glyccyrhizin, glycyrrhetinic acid.
Mini-Reviews in Organic Chemistry
Title:Recent Developments in the Synthesis of Antitumor-active Glycyrrhetinic Acid Derivatives
Volume: 11 Issue: 3
Author(s): Rene Csuk
Affiliation:
Keywords: Antitumor activity, apoptosis, glyccyrhizin, glycyrrhetinic acid.
Abstract: A serious flaw of many chemotherapeutics employed now for the (post-surgery) treatment of malignant tumors is their high cytotoxicity against vital organs. In addition, tumor cells that survive chemotherapy often show pronounced drug resistance against a wide range of therapeutics. Recently, glycyrrhetinic acid derivatives derived from a cheap and easy-to-obtain natural product have attracted pharmacological interest. Many derivatives of glycyrrhetinic acid showed good to excellent cytotoxicity and inhibited the proliferation of a wide range of human tumor cells. They act predominantly by apoptosis, thus making them an interesting and even fascinating starting point for the development of selective, effective and safe antitumor active drugs.
Export Options
About this article
Cite this article as:
Csuk Rene, Recent Developments in the Synthesis of Antitumor-active Glycyrrhetinic Acid Derivatives, Mini-Reviews in Organic Chemistry 2014; 11 (3) . https://dx.doi.org/10.2174/1570193X1103140915105049
DOI https://dx.doi.org/10.2174/1570193X1103140915105049 |
Print ISSN 1570-193X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6298 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Oxidative stress and myocarditis
Current Pharmaceutical Design Nuclear Imaging of Inflammation in Neurologic and Psychiatric Disorders
Current Clinical Pharmacology Emerging β-Amyloid Therapies for the Treatment of Alzheimers Disease
Current Pharmaceutical Design Neurodegeneration with Dementia: From Fundamentals of Pathology to Clinical Imaging by MRI and SPECT.
Current Medical Imaging The Host Complement System and Arbovirus Pathogenesis
Current Drug Targets Treatment of Epileptic Encephalopathies
Current Pharmaceutical Design Brain Targeted Drug Delivery: Factors, Approaches and Patents
Recent Patents on Nanomedicine Recent Advances and Approaches in Targeting Apoptosis Signaling Pathways for Anti-Cancer Therapeutics
Current Cancer Therapy Reviews Pathogenesis and Immune Status in COVID-19 Pneumonia - A Minireview
Coronaviruses Chemotherapy In Japanese Encephalitis: Are We There Yet?
Infectious Disorders - Drug Targets Filariasis: Current Status, Treatment and Recent Advances in Drug Development
Current Medicinal Chemistry The Seattle Structural Genomics Center for Infectious Disease (SSGCID)
Infectious Disorders - Drug Targets ABC Transporters in the CNS – An Inventory
Current Pharmaceutical Biotechnology β-Catenin/TCF-4 Signaling Regulates Susceptibility of Macrophages and Resistance of Monocytes to HIV-1 Productive Infection
Current HIV Research Patent Selections
Recent Patents on CNS Drug Discovery (Discontinued) Immune Therapy for Infectious Diseases at the Dawn of the 21st Century: the Past, Present and Future Role of Antibody Therapy, Therapeutic Vaccination and Biological Response Modifiers
Current Pharmaceutical Design Viral Myocarditis and Dilated Cardiomyopathy: Etiology and Pathogenesis
Current Pharmaceutical Design Subject Index To Volume 4
Current HIV Research Genetic and Molecular Basis of QTL of Diabetes in Mouse: Genes and Polymorphisms
Current Genomics Therapeutic Options in Prevention and Treatment of Aspartoacylase Gene Mutation Resulting Abnormalities in Canavan Disease
Current Pharmacogenomics